ACCESS TO MEFICINE IN THE GLOBAL ECONOMYPDF电子书下载

PART ONE BACKGROUND 3

1. From Conception to Commercial Success 3

2. A Limitation on the Patent Right to Exclude: An Introduction to International Exhaustion 35

PART TWO THE CURRENT FRAMEWORK 55

3. An Introduction to TRIPS 55

4. Freedom under TRIPS: India as an Example 89

5. Compulsory Licensing under TRIPS: An Introduction 125

6. Compulsory License Case Study: An Introduction to Competing Patent Perspectives 157

7. Complicated Compulsory Licenses: The Waiver/Article 31bis "Solution" 195

PART THREE THE EVOLVING FRAMEWORK 223

8. An Overview of "TRIPS-Plus" Standards 223

9. Beyond Patents: Protecting Drugs through Regulatory Laws 253

10. Suspensions of In-Transit "Generic Drugs": A Case Study of Competing Perspectives 285

11. A History of Access to Medicine through the Lens of Patent Perspectives 325

12. Looking Toward the Future 355

APPENDICES 375

Appendix A: Selected TRIPS Provisions 375

Appendix B: Declaration on the TRIPS Agreement and Public Health 382

Appendix C: Draft Ministerial Declaration (Developed Countries) 384

Appendix D: Draft Ministerial Declaration (Developing Countries) 386

Appendix E: Glossary of Terms 390

INDEX 399